Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Bladder Cancer
Interventions
BIOLOGICAL

Mycobacterium w

Immunomodulator

Trial Locations (17)

141008

Christian Medical College, Ludhiana

452014

Choithram Hospital and Research Centre, Indore

Unknown

Aarogyam Speciality Hospital, Ahmedabad

Gandhi Urocare, Ahmedabad

Siddhi Vinayak Hospital, Advanced Urology and Orthopedic Centre, Ahmedabad

Muljibhai Patel Urological Hospital, Nadiād

Urocare Hospital, Rajkot

Excel Hospital, Advanced Laproscopy and Urology Centre, Surat

Desai Urological & Maternity Hospital, Vadodara

Indira Gandhi Medical College, Shimla

Lourdes Hospital, Kochi

Cancer Hospital and Research Institute, Gwalior

S.P. Medical College & A. G. of Hospitals, Bikaner

IPGMER, S.S.K.M. Hospital, Kolkata

Post Graduate Institute of Medical Education and Research, Chandigarh

Dr. Ram Manohar Lohia Hospital & PGIMER, New Delhi

V. M. Medical College & Safdarjang Hospital, New Delhi

Sponsors
All Listed Sponsors
lead

Cadila Pharnmaceuticals

INDUSTRY

NCT00694798 - Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder | Biotech Hunter | Biotech Hunter